Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 239 articles:
HTML format



Single Articles


    May 2020
  1. PAGANO P, Marra A, Shinabarger D, Pillar C, et al
    In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium.
    J Antimicrob Chemother. 2020 May 19. pii: 5840661. doi: 10.1093.
    PubMed     Abstract available


  2. EICHEL V, Klein S, Bootsveld C, Frank U, et al
    Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
    J Antimicrob Chemother. 2020 May 15. pii: 5837672. doi: 10.1093.
    PubMed     Abstract available


  3. MANOHARAN A, Das T, Whiteley GS, Glasbey T, et al
    The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2020 May 3. pii: 5828489. doi: 10.1093.
    PubMed     Abstract available


  4. KADURA S, King N, Nakhoul M, Zhu H, et al
    Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.
    J Antimicrob Chemother. 2020 May 3. pii: 5828363. doi: 10.1093.
    PubMed     Abstract available


  5. BAKTHAVATCHALAM YD, Shankar A, Muniyasamy R, Peter JV, et al
    Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital.
    J Antimicrob Chemother. 2020 May 3. pii: 5828350. doi: 10.1093.
    PubMed     Abstract available


  6. THIEME L, Hartung A, Makarewicz O, Pletz MW, et al
    In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
    J Antimicrob Chemother. 2020 May 1. pii: 5827806. doi: 10.1093.
    PubMed     Abstract available


  7. RIEG S, Ernst A, Peyerl-Hoffmann G, Joost I, et al
    Combination therapy with rifampicin or fosfomycin in patients with Staphylococcus aureus bloodstream infection at high risk for complications or relapse: results of a large prospective observational cohort.
    J Antimicrob Chemother. 2020 May 1. pii: 5827555. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  8. MELETIADIS J, Siopi M, Kanioura L, Jorgensen KM, et al
    A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.
    J Antimicrob Chemother. 2020 Apr 24. pii: 5824917. doi: 10.1093.
    PubMed     Abstract available


  9. YOSHIDA S, Iwamoto T, Arikawa K, Sekizuka T, et al
    Bacterial population kinetics in heteroresistant Mycobacterium tuberculosis harbouring rare resistance-conferring mutations in gyrA and rpoB imply an epistatic interaction of mutations in a pre-XDR-TB patient.
    J Antimicrob Chemother. 2020 Apr 17. pii: 5821489. doi: 10.1093.
    PubMed     Abstract available


  10. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


  11. BROWN E, Gould FK
    Oral antibiotics for infective endocarditis: a clinical review.
    J Antimicrob Chemother. 2020 Apr 2. pii: 5815249. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  12. CAMPBELL AJ, Daley DA, Bell JM, Pang S, et al
    Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia.
    J Antimicrob Chemother. 2020 Mar 10. pii: 5802603. doi: 10.1093.
    PubMed     Abstract available


  13. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


  14. ABAD L, Josse J, Tasse J, Lustig S, et al
    Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin.
    J Antimicrob Chemother. 2020 Mar 3. pii: 5775582. doi: 10.1093.
    PubMed     Abstract available


  15. RUBIN IMC, Pedersen MS, Mollerup S, Kaya H, et al
    Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study.
    J Antimicrob Chemother. 2020 Mar 3. pii: 5775585. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  16. GROWCOTT EJ, Gamboa L, Roth T, Lopez S, et al
    Efficacy of piperacillin in combination with novel beta-lactamase inhibitor IID572 against beta-lactamase-producing strains of Enterobacteriaceae and Staphylococcus aureus in murine neutropenic thigh infection models.
    J Antimicrob Chemother. 2020 Feb 28. pii: 5766087. doi: 10.1093.
    PubMed     Abstract available


  17. NICOLAS R, Carricajo A, Morel J, Rigaill J, et al
    Evaluation of effectiveness and compliance with the mupirocin nasal ointment part of Staphylococcus aureus decolonization in real life using UPLC-MS/MS mupirocin quantification.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757992. doi: 10.1093.
    PubMed     Abstract available


  18. HUANG J, Wang M, Gao Y, Chen L, et al
    Erratum to: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757995. doi: 10.1093.
    PubMed    


  19. HUANG J, Wang M, Gao Y, Chen L, et al
    Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin-authors' response.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757983. doi: 10.1093.
    PubMed    


  20. EISENBERGER D, Tuschak C, Werner M, Bogdan C, et al
    Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.
    J Antimicrob Chemother. 2020 Feb 21. pii: 5743460. doi: 10.1093.
    PubMed     Abstract available


  21. KUEHL R, Morata L, Meylan S, Mensa J, et al
    When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722234. doi: 10.1093.
    PubMed     Abstract available


  22. HAGSTRAND ALDMAN M, Pahlman LI
    Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722233. doi: 10.1093.
    PubMed     Abstract available


  23. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  24. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  25. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  26. BROTHERTON AL, Rab S, Kandiah S, Kriengkauykiat J, et al
    The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteraemia utilizing the electronic health record.
    J Antimicrob Chemother. 2020 Jan 13. pii: 5702184. doi: 10.1093.
    PubMed     Abstract available


  27. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  28. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  29. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


  30. ALAM F, Catlow D, Di Maio A, Blair JMA, et al
    Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm.
    J Antimicrob Chemother. 2019 Dec 22. pii: 5684825. doi: 10.1093.
    PubMed     Abstract available


  31. WEGENER A, Damborg P, Guardabassi L, Moodley A, et al
    Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2019 Dec 17. pii: 5679833. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  32. KIM HW, Seok YS, Rhee MS
    Synergistic staphylocidal interaction of benzoic acid derivatives (benzoic acid, 4-hydroxybenzoic acid and beta-resorcylic acid) and capric acid: mechanism and verification study using artificial skin.
    J Antimicrob Chemother. 2019 Nov 28. pii: 5645158. doi: 10.1093.
    PubMed     Abstract available


  33. SUN L, Chen Y, Hua X, Chen Y, et al
    Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococci.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632032. doi: 10.1093.
    PubMed     Abstract available


  34. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  35. VALANEJAD S, Hill B
    Treatment failure of daptomycin for Streptococcus parasanguinis meningitis.
    J Antimicrob Chemother. 2019 Nov 7. pii: 5614368. doi: 10.1093.
    PubMed    


  36. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  37. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  38. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  39. URUSHIBARA N, Aung MS, Kawaguchiya M, Kobayashi N, et al
    Novel staphylococcal cassette chromosome mec (SCCmec) type XIV (5A) and a truncated SCCmec element in SCC composite islands carrying speG in ST5 MRSA in Japan.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588584. doi: 10.1093.
    PubMed     Abstract available


  40. ROCH M, Varela MC, Taglialegna A, Rosato AE, et al
    Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588582. doi: 10.1093.
    PubMed     Abstract available


  41. FREITAS AR, Novais C, Coque TM, Peixe L, et al
    Comment on: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588578. doi: 10.1093.
    PubMed    


  42. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  43. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  44. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


  45. VARMA GYN, Kummari G, Paik P, Kalle AM, et al
    Celecoxib potentiates antibiotic uptake by altering membrane potential and permeability in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581809. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  46. TOTH Z, Forgacs L, Locke JB, Kardos G, et al
    In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
    J Antimicrob Chemother. 2019 Sep 20. pii: 5572326. doi: 10.1093.
    PubMed     Abstract available


  47. PEIFFER-SMADJA N, Guillotel E, Luque-Paz D, Maataoui N, et al
    In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
    J Antimicrob Chemother. 2019 Sep 8. pii: 5565277. doi: 10.1093.
    PubMed     Abstract available


  48. ANTONELLI A, Giani T, Coppi M, Di Pilato V, et al
    Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    J Antimicrob Chemother. 2019 Sep 6. pii: 5563998. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  49. WARDENBURG KE, Potter RF, D'Souza AW, Hussain T, et al
    Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.
    J Antimicrob Chemother. 2019 Aug 23. pii: 5553751. doi: 10.1093.
    PubMed     Abstract available


  50. BOJANG A, Baines SL, Donovan L, Guerillot R, et al
    Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin.
    J Antimicrob Chemother. 2019 Aug 19. pii: 5551401. doi: 10.1093.
    PubMed     Abstract available


  51. TEN OEVER J, Jansen JL, van der Vaart TW, Schouten JA, et al
    Development of quality indicators for the management of Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Aug 8. pii: 5545103. doi: 10.1093.
    PubMed     Abstract available


  52. FULLER J, Dingle TC, Bull A, Shokoples S, et al
    Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  53. GOLDEN AR, Baxter MR, Davidson RJ, Martin I, et al
    Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    July 2019
  54. COLLEY T, Sharma C, Alanio A, Kimura G, et al
    Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
    J Antimicrob Chemother. 2019 Jul 30. pii: 5540742. doi: 10.1093.
    PubMed     Abstract available


  55. COUPRI D, Budin-Verneuil A, Hartke A, Benachour A, et al
    Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to beta-lactams.
    J Antimicrob Chemother. 2019 Jul 24. pii: 5538001. doi: 10.1093.
    PubMed     Abstract available


  56. KLARE I, Bender JK, Fleige C, Kriebel N, et al
    Comparison of VITEK(R) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
    J Antimicrob Chemother. 2019 Jul 23. pii: 5537362. doi: 10.1093.
    PubMed     Abstract available


  57. RUDRAMURTHY SM, Colley T, Abdolrasouli A, Ashman J, et al
    In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
    J Antimicrob Chemother. 2019 Jul 19. pii: 5536332. doi: 10.1093.
    PubMed     Abstract available


  58. SHANG Y, Li D, Hao W, Schwarz S, et al
    A prophage and two ICESa2603-family integrative and conjugative elements (ICEs) carrying optrA in Streptococcus suis.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533309. doi: 10.1093.
    PubMed     Abstract available


  59. HURLEY JC
    Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533112. doi: 10.1093.
    PubMed     Abstract available


  60. DUSS FR, Garcia de la Maria C, Croxatto A, Giulieri S, et al
    Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    J Antimicrob Chemother. 2019 Jul 11. pii: 5531247. doi: 10.1093.
    PubMed     Abstract available


  61. MEHTA K, Ravimohan S, Pasipanodya JG, Srivastava S, et al
    Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.
    J Antimicrob Chemother. 2019 Jul 4. pii: 5528382. doi: 10.1093.
    PubMed     Abstract available


  62. PI R, Liu Q, Jiang Q, Gao Q, et al
    Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS.
    J Antimicrob Chemother. 2019;74:1795-1798.
    PubMed     Abstract available


  63. WURSTER S, Bandi A, Beyda ND, Albert ND, et al
    Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    J Antimicrob Chemother. 2019;74:1904-1910.
    PubMed     Abstract available


  64. GONZALEZ-LARA MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, et al
    Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    J Antimicrob Chemother. 2019;74:2047-2050.
    PubMed     Abstract available


    June 2019
  65. ELGHAIEB H, Freitas AR, Abbassi MS, Novais C, et al
    Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523711. doi: 10.1093.
    PubMed     Abstract available


  66. CHANCHAITHONG P, Perreten V, Schwendener S
    Macrococcus canis contains recombinogenic methicillin resistance elements and the mecB plasmid found in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523695. doi: 10.1093.
    PubMed     Abstract available


  67. HUANG J, Wang M, Gao Y, Chen L, et al
    Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522517. doi: 10.1093.
    PubMed     Abstract available


  68. RESENDIZ-SHARPE A, Mercier T, Lestrade PPA, van der Beek MT, et al
    Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522515. doi: 10.1093.
    PubMed     Abstract available


  69. LEON-SAMPEDRO R, Fernandez-de-Bobadilla MD, San Millan A, Baquero F, et al
    Transfer dynamics of Tn6648, a composite integrative conjugative element generated by tandem accretion of Tn5801 and Tn6647 in Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Jun 21. pii: 5521775. doi: 10.1093.
    PubMed     Abstract available


  70. LENHARD JR, Smith NM, Quach CD, Nguyen TQ, et al
    Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
    J Antimicrob Chemother. 2019 Jun 20. pii: 5521061. doi: 10.1093.
    PubMed     Abstract available


  71. SHEN P, Zhou K, Wang Y, Song J, et al
    High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    J Antimicrob Chemother. 2019 Jun 15. pii: 5519372. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  72. PINTO SN, Dias SA, Cruz AF, Mil-Homens D, et al
    The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms.
    J Antimicrob Chemother. 2019 May 24. pii: 5498604. doi: 10.1093.
    PubMed     Abstract available


  73. JAJOU R, van der Laan T, de Zwaan R, Kamst M, et al
    WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    J Antimicrob Chemother. 2019 May 22. pii: 5497435. doi: 10.1093.
    PubMed     Abstract available


  74. CHANG SC, Lin LC, Ge MC, Liu TP, et al
    Characterization of a novel, type II staphylococcal cassette chromosome mec element from an endemic oxacillin-resistant Staphylococcus lugdunensis clone in a hospital setting.
    J Antimicrob Chemother. 2019 May 18. pii: 5491489. doi: 10.1093.
    PubMed     Abstract available


  75. MORIO F, Lombardi L, Binder U, Loge C, et al
    Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491491. doi: 10.1093.
    PubMed     Abstract available


  76. MELETIADIS J, Siopi M, Kanioura L, Jorgensen KM, et al
    Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
    J Antimicrob Chemother. 2019 May 18. pii: 5491493. doi: 10.1093.
    PubMed     Abstract available


  77. LEI CW, Kang ZZ, Wu SK, Chen YP, et al
    Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
    J Antimicrob Chemother. 2019 May 18. pii: 5491555. doi: 10.1093.
    PubMed    


  78. YUSTE JR, Serrano-Alonso M, Carmona-Torre F, Del Pozo JL, et al
    Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491490. doi: 10.1093.
    PubMed    


  79. DUDIUK C, Berrio I, Leonardelli F, Morales-Lopez S, et al
    Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    J Antimicrob Chemother. 2019 May 12. pii: 5488498. doi: 10.1093.
    PubMed     Abstract available


  80. REED JM, Gardner SG, Mishra NN, Bayer AS, et al
    Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 May 10. pii: 5487738. doi: 10.1093.
    PubMed     Abstract available


  81. LORENZO MP, Kidd JM, Jenkins SG, Nicolau DP, et al
    In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
    J Antimicrob Chemother. 2019 May 3. pii: 5485296. doi: 10.1093.
    PubMed     Abstract available


  82. BARMAN TK, Kumar M, Chaira T, Gangadharan R, et al
    Potential of the fluoroketolide RBx 14255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model.
    J Antimicrob Chemother. 2019 May 2. pii: 5485015. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  83. LAVERGNE RA, Morio F, Danner-Boucher I, Horeau-Langlard D, et al
    One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
    J Antimicrob Chemother. 2019 Apr 30. pii: 5481886. doi: 10.1093.
    PubMed     Abstract available


  84. PAPAGIANNITSIS CC, Tsilipounidaki K, Malli E, Petinaki E, et al
    Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
    J Antimicrob Chemother. 2019 Apr 22. pii: 5476265. doi: 10.1093.
    PubMed    


  85. WICHA WW, Strickmann DB, Paukner S
    Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    March 2019
  86. PINHOLT M, Bayliss SC, Gumpert H, Worning P, et al
    WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome.
    J Antimicrob Chemother. 2019 Mar 30. pii: 5423852. doi: 10.1093.
    PubMed     Abstract available


  87. SASSI M, Guerin F, Zouari A, Beyrouthy R, et al
    Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.
    J Antimicrob Chemother. 2019 Mar 20. pii: 5416192. doi: 10.1093.
    PubMed     Abstract available


  88. RIVERO-MENENDEZ O, Cuenca-Estrella M, Alastruey-Izquierdo A
    In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396709. doi: 10.1093.
    PubMed     Abstract available


  89. HAO W, Shan X, Li D, Schwarz S, et al
    Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396705. doi: 10.1093.
    PubMed     Abstract available


  90. VASUDEVAN S, Durai RD, Chellappan DR, Narayanan VHB, et al
    A polymer-based anti-quorum catheter coating to challenge MDR Staphylococcus aureus: in vivo and in vitro approaches.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377359. doi: 10.1093.
    PubMed     Abstract available


  91. HASMAN H, Clausen PTLC, Kaya H, Hansen F, et al
    LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377356. doi: 10.1093.
    PubMed     Abstract available


  92. MAXWELL-SCOTT H, Thangarajah R, Arnold A, Wade P, et al
    Successful treatment of Pseudomonas aeruginosa infective endocarditis via haemodialysis outpatient parenteral antimicrobial therapy: case report.
    J Antimicrob Chemother. 2019 Mar 4. pii: 5369201. doi: 10.1093.
    PubMed    


    February 2019
  93. PERISELNERIS J, Nwankwo L, Schelenz S, Shah A, et al
    Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    J Antimicrob Chemother. 2019 Feb 25. pii: 5364630. doi: 10.1093.
    PubMed     Abstract available


  94. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Abstract available


  95. HU Y, Pertinez H, Liu Y, Davies G, et al
    Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    J Antimicrob Chemother. 2019 Feb 20. pii: 5353164. doi: 10.1093.
    PubMed     Abstract available


  96. KANG J, Dietz MJ, Hughes K, Xing M, et al
    Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 18. pii: 5333167. doi: 10.1093.
    PubMed     Abstract available


  97. BA X, Kalmar L, Hadjirin NF, Kerschner H, et al
    Truncation of GdpP mediates beta-lactam resistance in clinical isolates of Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 12. pii: 5316432. doi: 10.1093.
    PubMed     Abstract available


  98. SINGH A, Singh PK, de Groot T, Kumar A, et al
    Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315659. doi: 10.1093.
    PubMed     Abstract available


  99. LAMOTH F, Mercier T, Andre P, Pagani JL, et al
    Isavuconazole brain penetration in cerebral aspergillosis.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315664. doi: 10.1093.
    PubMed    


  100. NIKOLAYEVSKYY V, Maurer FP, Holicka Y, Taylor L, et al
    Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315667. doi: 10.1093.
    PubMed     Abstract available


  101. WU T, Meyer K, Harrington AT, Danziger LH, et al
    In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2019 Feb 8. pii: 5310330. doi: 10.1093.
    PubMed     Abstract available


  102. DAS S, Garg T, Chopra S, Dasgupta A, et al
    Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309031. doi: 10.1093.
    PubMed     Abstract available


  103. SADER HS, Mendes RE, Pfaller MA, Flamm RK, et al
    Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309029. doi: 10.1093.
    PubMed     Abstract available


  104. PAUL S, Singh S, Chakrabarti A, Rudramurthy SM, et al
    Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    J Antimicrob Chemother. 2019 Feb 6. pii: 5307967. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  105. PEREZ-RODRIGUEZ MT, Sousa A, Lopez-Cortes LE, Martinez-Lamas L, et al
    Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Jan 27. pii: 5303230. doi: 10.1093.
    PubMed     Abstract available


  106. DEL PRINCIPE MI, Dragonetti G, Verga L, Candoni A, et al
    'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
    J Antimicrob Chemother. 2019 Jan 14. pii: 5289513. doi: 10.1093.
    PubMed     Abstract available


  107. KITAMURA M, Kimura K, Ido A, Seki T, et al
    Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
    J Antimicrob Chemother. 2019 Jan 11. pii: 5288581. doi: 10.1093.
    PubMed     Abstract available


  108. MORRONI G, Brenciani A, Litta-Mulondo A, Vignaroli C, et al
    Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288148. doi: 10.1093.
    PubMed     Abstract available


  109. RUTH MM, Sangen JJN, Remmers K, Pennings LJ, et al
    A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288158. doi: 10.1093.
    PubMed     Abstract available


  110. DE JONG A, Simjee S, Rose M, Moyaert H, et al
    Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study).
    J Antimicrob Chemother. 2019 Jan 8. pii: 5280942. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  111. KOSMIDIS C, Rodriguez-Goncer I, Rautemaa-Richardson R, Richardson MD, et al
    Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
    J Antimicrob Chemother. 2018 Dec 26. pii: 5262264. doi: 10.1093.
    PubMed     Abstract available


  112. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Abstract available


  113. RYBAK JM, Fortwendel JR, Rogers PD
    Emerging threat of triazole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Dec 17. pii: 5250853. doi: 10.1093.
    PubMed     Abstract available


  114. KIDD JM, Abdelraouf K, Nicolau DP
    Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    J Antimicrob Chemother. 2018 Dec 14. pii: 5248203. doi: 10.1093.
    PubMed     Abstract available


  115. BRENCIANI A, Fioriti S, Morroni G, Cucco L, et al
    Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230877. doi: 10.1093.
    PubMed    


  116. ABAD L, Tafani V, Tasse J, Josse J, et al
    Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230874. doi: 10.1093.
    PubMed     Abstract available


  117. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Abstract available


  118. AKKERMAN OW, Alffenaar JWC
    Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Dec 1. pii: 5224542. doi: 10.1093.
    PubMed    


    November 2018
  119. JIANG N, Li J, Fessler AT, Wang Y, et al
    Novel pseudo-staphylococcal cassette chromosome mec element (phiSCCmecT55) in MRSA ST9.
    J Antimicrob Chemother. 2018 Nov 15. pii: 5184555. doi: 10.1093.
    PubMed    


  120. TREVINO-RANGEL RJ, Villanueva-Lozano H, Mendez-Galomo KS, Solis-Villegas EM, et al
    In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Nov 6. pii: 5162960. doi: 10.1093.
    PubMed     Abstract available


  121. LACKNER M, Birch M, Naschberger V, Grassle D, et al
    Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
    J Antimicrob Chemother. 2018;73:3068-3073.
    PubMed     Abstract available


    October 2018
  122. DAS S, Li J, Iaconis J, Zhou D, et al
    Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
    J Antimicrob Chemother. 2018 Oct 31. pii: 5150590. doi: 10.1093.
    PubMed     Abstract available


  123. NADERI J, Giles C, Saboohi S, Griesser HJ, et al
    Surface coatings with covalently attached anidulafungin and micafungin prevent Candida albicans biofilm formation.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146520. doi: 10.1093.
    PubMed     Abstract available


  124. TROEMAN DPR, Van Hout D, Kluytmans JAJW
    Antimicrobial approaches in the prevention of Staphylococcus aureus infections: a review.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146516. doi: 10.1093.
    PubMed     Abstract available


  125. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Abstract available


  126. HSUEH SC, Lee YJ, Huang YT, Liao CH, et al
    In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstr
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144002. doi: 10.1093.
    PubMed     Abstract available


  127. BROSH-NISSIMOV T, Navon-Venezia S, Keller N, Amit S, et al
    Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults.
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144000. doi: 10.1093.
    PubMed     Abstract available


  128. CAMPBELL AJ, Dotel R, Blyth CC, Davis JS, et al
    Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.
    J Antimicrob Chemother. 2018 Oct 10. pii: 5126432. doi: 10.1093.
    PubMed     Abstract available


  129. DOAN TN, Fox GJ, Meehan MT, Scott N, et al
    Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116208. doi: 10.1093.
    PubMed     Abstract available


  130. TYSON GH, Sabo JL, Hoffmann M, Hsu CH, et al
    Novel linezolid resistance plasmids in Enterococcus from food animals in the USA.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5106682. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  131. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Abstract available


  132. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Abstract available


  133. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Abstract available


  134. CHANNABASAPPA S, Chikkamadaiah R, Durgaiah M, Kumar S, et al
    Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095203. doi: 10.1093.
    PubMed     Abstract available


  135. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  136. PASQUAROLI S, Citterio B, Mangiaterra G, Biavasco F, et al
    Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    J Antimicrob Chemother. 2018 Aug 29. pii: 5086495. doi: 10.1093.
    PubMed    


  137. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Abstract available


  138. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed    


  139. RIGAILL J, Morgene MF, Gavid M, Lelonge Y, et al
    Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.
    J Antimicrob Chemother. 2018 Aug 16. pii: 5075188. doi: 10.1093.
    PubMed     Abstract available


  140. DEPLANO A, Dodemont M, Denis O, Westh H, et al
    European external quality assessments for identification, molecular typing and characterization of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Aug 7. pii: 5067736. doi: 10.1093.
    PubMed     Abstract available


  141. HANSEN TA, Pedersen MS, Nielsen LG, Ma CMG, et al
    Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
    J Antimicrob Chemother. 2018 Aug 2. pii: 5064278. doi: 10.1093.
    PubMed     Abstract available


  142. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  143. WIEDERHOLD NP, Locke JB, Daruwala P, Bartizal K, et al
    Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    J Antimicrob Chemother. 2018 Jul 18. pii: 5055842. doi: 10.1093.
    PubMed     Abstract available


  144. ROGIERS O, Holtappels M, Siala W, Lamkanfi M, et al
    Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    J Antimicrob Chemother. 2018 Jul 13. pii: 5053967. doi: 10.1093.
    PubMed     Abstract available


  145. WHITFIELD MG, Warren RM, Mathys V, Scott L, et al
    The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Jul 5. pii: 5049577. doi: 10.1093.
    PubMed     Abstract available


  146. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  147. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  148. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  149. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    June 2018
  150. GARVEY EP, Sharp AD, Warn PA, Yates CM, et al
    The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    J Antimicrob Chemother. 2018 Jun 26. pii: 5045560. doi: 10.1093.
    PubMed     Abstract available


  151. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Abstract available


  152. BOUDJEMAA R, Steenkeste K, Jacqueline C, Briandet R, et al
    Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036450. doi: 10.1093.
    PubMed     Abstract available


  153. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  154. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Abstract available


  155. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 May 25. pii: 5003466. doi: 10.1093.
    PubMed    


  156. BREAK TJ, Desai JV, Healey KR, Natarajan M, et al
    VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    J Antimicrob Chemother. 2018 May 16. pii: 4996888. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  157. SEUFERT R, Sedlacek L, Kahl B, Hogardt M, et al
    Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4978322. doi: 10.1093.
    PubMed     Abstract available


  158. HAGER CL, Larkin EL, Long LA, Ghannoum MA, et al
    Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4979534. doi: 10.1093.
    PubMed     Abstract available


  159. RIZZATO C, Poma N, Zoppo M, Posteraro B, et al
    CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
    J Antimicrob Chemother. 2018 Apr 9. pii: 4964989. doi: 10.1093.
    PubMed     Abstract available


  160. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2018 Apr 5. pii: 4962127. doi: 10.1093.
    PubMed    


  161. HASHEMI MM, Rovig J, Holden BS, Taylor MF, et al
    Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960903. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  162. CANEZIN PH, Caleffi-Ferracioli KR, Scodro RBL, Siqueira VLD, et al
    Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951545. doi: 10.1093.
    PubMed     Abstract available


  163. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Abstract available


  164. DALL GF, Tsang SJ, Gwynne PJ, MacKenzie SP, et al
    Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937886. doi: 10.1093.
    PubMed     Abstract available


  165. CARTER GP, Harjani JR, Li L, Pitcher NP, et al
    1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    J Antimicrob Chemother. 2018 Mar 6. pii: 4922693. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  166. THIEME L, Klinger-Strobel M, Hartung A, Stein C, et al
    In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913717. doi: 10.1093.
    PubMed     Abstract available


  167. MCCARTY TP, Lockhart SR, Moser SA, Whiddon J, et al
    Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913721. doi: 10.1093.
    PubMed     Abstract available


  168. RODRIGUEZ-CASTRO E, Trastoy R, Rodriguez-Osorio X, Dominguez-Santalla MJ, et al
    Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: a case report.
    J Antimicrob Chemother. 2018 Feb 21. pii: 4898172. doi: 10.1093.
    PubMed    


  169. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Abstract available


  170. WESSELS C, Strommenger B, Klare I, Bender J, et al
    Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847818. doi: 10.1093.
    PubMed     Abstract available


  171. KAMBAREV S, Pecorari F, Corvec S
    Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847819. doi: 10.1093.
    PubMed     Abstract available


  172. SUN C, Zhang P, Ji X, Fan R, et al
    Presence and molecular characteristics of oxazolidinone resistance in staphylococci from household animals in rural China.
    J Antimicrob Chemother. 2018 Feb 7. pii: 4841776. doi: 10.1093.
    PubMed     Abstract available


  173. HUH HJ, Song DJ, Shim HJ, Kwon WK, et al
    Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.
    J Antimicrob Chemother. 2018 Feb 3. pii: 4837262. doi: 10.1093.
    PubMed     Abstract available


  174. NEVES FPG, Cardoso NT, Souza ARV, Snyder RE, et al
    Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    J Antimicrob Chemother. 2018 Feb 1. pii: 4833983. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  175. LESTRADE PP, van der Velden WJFM, Bouwman F, Stoop FJ, et al
    Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4831957. doi: 10.1093.
    PubMed     Abstract available


  176. DOOKIE N, Rambaran S, Padayatchi N, Mahomed S, et al
    Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817621. doi: 10.1093.
    PubMed     Abstract available


  177. LAYER F, Vourli S, Karavasilis V, Strommenger B, et al
    Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817623. doi: 10.1093.
    PubMed     Abstract available


  178. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Abstract available


  179. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Abstract available


  180. CHOWDHARY A, Prakash A, Sharma C, Kordalewska M, et al
    A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4794718. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  181. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Abstract available


  182. EDSLEV SM, Clausen ML, Agner T, Stegger M, et al
    Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745837. doi: 10.1093.
    PubMed     Abstract available


  183. LIU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    J Antimicrob Chemother. 2017 Dec 12. pii: 4735127. doi: 10.1093.
    PubMed     Abstract available


  184. CHEN C, Hooper DC
    Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693732. doi: 10.1093.
    PubMed     Abstract available


  185. ZHANG P, Wright JA, Tymon A, Nair SP, et al
    Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    J Antimicrob Chemother. 2017 Dec 4. pii: 4688916. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  186. PITT R, Alexander S, Ison C, Horner P, et al
    Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    J Antimicrob Chemother. 2017 Nov 30. pii: 4682922. doi: 10.1093.
    PubMed     Abstract available


  187. KONTOYIANNIS DP, Selleslag D, Mullane K, Cornely OA, et al
    Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    J Antimicrob Chemother. 2017 Nov 29. pii: 4675068. doi: 10.1093.
    PubMed     Abstract available


  188. WIEDERHOLD NP, Patterson HP, Tran BH, Yates CM, et al
    Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    J Antimicrob Chemother. 2017 Nov 27. pii: 4669681. doi: 10.1093.
    PubMed     Abstract available


  189. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Abstract available


  190. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2017 Nov 21. pii: 4644442. doi: 10.1093.
    PubMed     Abstract available


  191. FREITAS AR, Tedim AP, Novais C, Coque TM, et al
    Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  192. COSTA SS, Viveiros M, Pomba C, Couto I, et al
    Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    J Antimicrob Chemother. 2017 Nov 8. doi: 10.1093.
    PubMed     Abstract available


  193. GODET C, Alastruey-Izquierdo A, Flick H, Hennequin C, et al
    A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
    J Antimicrob Chemother. 2017 Nov 6. doi: 10.1093.
    PubMed     Abstract available


  194. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Nov 3. doi: 10.1093.
    PubMed    


    October 2017
  195. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  196. VYAZOVAYA A, Levina K, Zhuravlev V, Viiklepp P, et al
    Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  197. FOSCHI C, Salvo M, Cevenini R, Marangoni A, et al
    Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    J Antimicrob Chemother. 2017 Oct 25. doi: 10.1093.
    PubMed     Abstract available


  198. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  199. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  200. SEAS C, Garcia C, Salles MJ, Labarca J, et al
    Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
    J Antimicrob Chemother. 2017 Oct 17. doi: 10.1093.
    PubMed     Abstract available


  201. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Abstract available


  202. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed    


  203. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Abstract available


  204. YEW WW, Liang D, Chan DP, Shi W, et al
    Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017;72:2943-2944.
    PubMed    


  205. SINGH R, Almutairi M, Alm RA, Lahiri SD, et al
    Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    J Antimicrob Chemother. 2017;72:2796-2803.
    PubMed     Abstract available


  206. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Abstract available


  207. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Abstract available


  208. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Abstract available


  209. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Abstract available


    September 2017
  210. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  211. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Abstract available


  212. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Abstract available


  213. PASIPANODYA JG, Ogbonna D, Deshpande D, Srivastava S, et al
    Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  214. DESHPANDE D, Srivastava S, Gumbo T
    A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  215. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  216. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  217. DESHPANDE D, Srivastava S, Pasipanodya JG, Gumbo T, et al
    Linezolid as treatment for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  218. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


    August 2017
  219. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  220. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Abstract available


  221. GONZALEZ MORENO M, Trampuz A, Di Luca M
    Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.
    J Antimicrob Chemother. 2017 Aug 21. doi: 10.1093.
    PubMed     Abstract available


  222. SINGH AK, Thakare R, Karaulia P, Das S, et al
    Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Abstract available


  223. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Abstract available


  224. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Abstract available


  225. COJUTTI PG, Candoni A, Ramos-Martin V, Lazzarotto D, et al
    Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
    J Antimicrob Chemother. 2017;72:2342-2350.
    PubMed     Abstract available


  226. CORNELY OA, Leguay T, Maertens J, Vehreschild MJGT, et al
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    J Antimicrob Chemother. 2017;72:2359-2367.
    PubMed     Abstract available


  227. TAUBERT M, Zander J, Frechen S, Scharf C, et al
    Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
    J Antimicrob Chemother. 2017;72:2304-2310.
    PubMed     Abstract available


  228. BEVAN ER, Jones AM, Hawkey PM
    Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype.
    J Antimicrob Chemother. 2017;72:2145-2155.
    PubMed     Abstract available


  229. AYDIN S, Personne Y, Newire E, Laverick R, et al
    Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
    J Antimicrob Chemother. 2017;72:2213-2218.
    PubMed     Abstract available


  230. MATSUMURA Y, Peirano G, Devinney R, Bradford PA, et al
    Genomic epidemiology of global VIM-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2249-2258.
    PubMed     Abstract available


  231. SVENSSON RJ, Gillespie SH, Simonsson USH
    Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    J Antimicrob Chemother. 2017;72:2311-2319.
    PubMed     Abstract available


  232. LIVERMORE DM, Mushtaq S, Meunier D, Hopkins KL, et al
    Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    J Antimicrob Chemother. 2017;72:2278-2289.
    PubMed     Abstract available


  233. BOTELHO J, Grosso F, Quinteira S, Mabrouk A, et al
    The complete nucleotide sequence of an IncP-2 megaplasmid unveils a mosaic architecture comprising a putative novel blaVIM-2-harbouring transposon in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2017;72:2225-2229.
    PubMed     Abstract available


  234. LAGACE-WIENS PRS, Adam HJ, Laing NM, Baxter MR, et al
    Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
    J Antimicrob Chemother. 2017;72:2273-2277.
    PubMed     Abstract available


  235. CHATTERJEE S, Mondal A, Mitra S, Basu S, et al
    Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
    J Antimicrob Chemother. 2017;72:2201-2207.
    PubMed     Abstract available


  236. VARGAS-PALACIOS A, Meads DM, Twiddy M, Czoski Murray C, et al
    Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    J Antimicrob Chemother. 2017;72:2392-2400.
    PubMed     Abstract available


  237. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Abstract available


  238. DOUMITH M, Findlay J, Hirani H, Hopkins KL, et al
    Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK.
    J Antimicrob Chemother. 2017;72:2241-2248.
    PubMed     Abstract available


    July 2017
  239. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: